GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ONCOTHYREON (ONTY) [hlAlert]

Rating:
Outperform
ONTY
up 52.15 %

ONCOTHYREON (ONTY) rated Outperform with price target $8 by Boenning & Scattergood

Posted on: Thursday,  Aug 13, 2009  9:25 AM ET by Boenning & Scattergood

Boenning & Scattergood rated Outperform ONCOTHYREON (NASDAQ: ONTY) on 08/13/2009. Previously Boenning & Scattergood rated Outperform ONCOTHYREON (NASDAQ: ONTY) on 06/18/2009.,
when the stock price was $2.32. Since then, ONCOTHYREON has gained 52.16% as of 01/14/2016's recent price of $3.53.
If you would have followed the previous Boenning & Scattergood's recommendation on ONTY, you would have gained 52.15% of your investment in 2401 days.

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company. The Company focuses primarily on the development of therapeutic products for the treatment of cancer. The Company?s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Oncothyreon?s lead product candidate is Stimuvax, which is a cancer vaccine in Phase III development for non-small cell lung cancer (NSCLC). Oncothyreon has an exclusive, worldwide license to Merck KGaA of Darmstadt, Germany (Merck KGaA), for the development, manufacture and commercialization of Stimuvax. Its pipeline of product candidates is consisted of cancer vaccines and small molecule candidates. The Company?s wholly owned subsidiaries include Oncothyreon Canada Inc., Biomira Management Inc., ProlX Pharmaceuticals Corporation, Biomira International Inc., Biomira BV and Oncothyreon Luxembourg.

Our equity research team concentrates on companies that aren’t widely covered in sectors such as water distribution/equipment/technology, financial services, business services, aerospace & defense technology, medical technology and retail.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2009 9:25 AM Buy
None
5.94 8.00
as of 12/31/2009
1 Week down  -38.72 %
1 Month down  -31.31 %
3 Months down  -41.07 %
1 YTD down  -43.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/18/2009 8:25 AM Buy
None
2.32 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy